BioSpine

Post-market drug interactions are dangerous reactions found after drugs are approved. Clinical trials miss them due to small studies and short durations. Systems like FAERS and Sentinel monitor millions of users to detect risks. Real examples include simvastatin with antifungals and grapefruit juice. Learn how to protect yourself from hidden drug risks.
Between 2023 and 2025, hundreds of generic drugs were approved by the FDA but blocked from market by patent lawsuits. This article breaks down how patent litigation delays affordable medications, costs patients billions, and why the system is broken.